LAEKNA-B 02105Hong Kong Stock Exchange

7.3703.03%( -0.230 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
LAEKNA-B (02105) Company Profile - Company Info, Industry & Management - cibo

Company Information

Market
HKEX Main Board
Listing Date
2023-06-29
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
KYG5340S1093

Industry

Innovative Drugs & Biologics 0.02%
124 stocks in this industry
Down 52 Up 57
Industry RankingsValue (HKD)Rank
Revenue (Last FY)125.15M88/112
Net Profit (Last FY)-268.91M89/125
ROE (Last FY)-19.43%79/117

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition
LU Chris Xiangyang Executive Director
XIE Ling Executive Director
GU Xiang-Ju Justin Executive Director
WANG David Guowei Non-Executive Director
SUN Yuan Non-Executive Director
YIN Xudong Independent Non-Executive Director
LI Min Independent Non-Executive Director
ZHOU Jian Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2025-12-12.

About this page

This page shows LAEKNA-B (02105) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.